GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Pre-Tax Income

SanBio Co (TSE:4592) Pre-Tax Income : 円-2,542.14 Mil (TTM As of Jan. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. SanBio Co's pretax income for the three months ended in Jan. 2024 was 円-800.10 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jan. 2024 was 円-2,542.14 Mil. SanBio Co's pretax margin was %.

During the past 11 years, SanBio Co's highest Pretax Margin was 69.00%. The lowest was -1153.00%. And the median was -310.89%.


SanBio Co Pre-Tax Income Historical Data

The historical data trend for SanBio Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Pre-Tax Income Chart

SanBio Co Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,156.51 -3,211.50 -4,560.42 -4,697.44 -2,542.14

SanBio Co Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,134.53 -866.30 -992.51 116.78 -800.10

Competitive Comparison of SanBio Co's Pre-Tax Income

For the Biotechnology subindustry, SanBio Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SanBio Co's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where SanBio Co's Pre-Tax Income falls into.



SanBio Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

SanBio Co's Pretax Income for the fiscal year that ended in Jan. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-4539.729+0+-10.548+2.465+2005.677
=-2,542.14

SanBio Co's Pretax Income for the quarter that ended in Jan. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-814.454+0+-2.341+0.525+16.169
=-800.10

Pre-Tax Income for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-2,542.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SanBio Co  (TSE:4592) Pre-Tax Income Explanation

SanBio Co's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-800.101/0
=%

During the past 11 years, SanBio Co's highest Pretax Margin was 69.00%. The lowest was -1153.00%. And the median was -310.89%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SanBio Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of SanBio Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


SanBio Co (TSE:4592) Business Description

Traded in Other Exchanges
Address
8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines